检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:殷胜利[1] 龚华荣[2] 李文华[2] 崔艳芬[2] 张萍[2] 吴相如[2] 汤蕴琦[2]
机构地区:[1]上海交通大学医学院附属新华医院(崇明)放射科,上海200092 [2]上海交通大学医学院附属新华医院,上海200092
出 处:《中国医药指南》2012年第26期3-5,共3页Guide of China Medicine
基 金:上海市卫生局(2008184)
摘 要:目的与手术病理分期比较,回顾性分析MRI对早期子宫内膜癌术前分期的准确性和判断肿瘤分级的价值。方法对122例经分段诊刮和手术病理证实的早期(Ⅰ-Ⅱ期)子宫内膜癌病例进行MR自旋回波T1WI、T2WI和DWI成像检查,观察肿瘤的信号、肿瘤范围、结合带显示及宫颈累及情况,测量ADC值,并进行T2WI和T2WI+DWI分期。结果 Ia期25例,Ib期64例;Ⅱ期33例。与正常子宫内膜相比,肿瘤T1WI呈等信号,T2WI呈高信号,DWI为明显高信号,增强后表现为中度强化。T2WI分期的敏感度为89.3%,特异度为91.0%,T2WI+DWI分期的敏感度为94.3%,特异度为93.5%。结论 T2WI联合DWI更有利于提高早期子宫内膜癌分期的准确性和判断肿瘤的分化程度。Objective To retrospectively evaluate the value of preoperative staging and grading of MR imaging compared with surgery-pathology proved Stage Ⅰ-Ⅱ Endometrial Carcinoma.Methods One hundred and twenty-two patients with pathological1y proved endometrial carcinomas were included in this retrospective study.All patients underwent spin-echo MR Tl-and T2-weighted imaging and diffusion-weighted imaging(DWI) and gadolinium-enhanced T1-weighted imaging.The signals,extent,appearance of junctional zone,depth of myometrial invasion and cervical invasion were recorded.The value of ADC measurement and tumor staging using T2-weighted imaging and combining T2-weighted imaging and DWI were performed.Results Of 122 patients,25 were Ia,64 were Ib,33 were II stage.All tumors were isointensity on T1-weighted images,hyperintensity on T2-weighted images and DWI with moderate enhancement compared with the normal endometrium.The sensitivity and specificity of tumor staging using T2-weighted imaging was 89.3% and 91.0% and combining T2-weighted imaging and DWI was 94.3% and 93.5% retrospectively.Conclusion The accuracy of staging of early endometrial carcinoma can be promoted and the tumor grading may be further evaluated with combining T2-weighted imaging and DWI.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.249